SAN

93.2

-0.8%↓

MRK1

114.3

-2.72%↓

SHL.DE

48.29

-1.15%↓

ARGX

516.8

-0.96%↓

FRE

43.29

-0.62%↓

SAN

93.2

-0.8%↓

MRK1

114.3

-2.72%↓

SHL.DE

48.29

-1.15%↓

ARGX

516.8

-0.96%↓

FRE

43.29

-0.62%↓

SAN

93.2

-0.8%↓

MRK1

114.3

-2.72%↓

SHL.DE

48.29

-1.15%↓

ARGX

516.8

-0.96%↓

FRE

43.29

-0.62%↓

SAN

93.2

-0.8%↓

MRK1

114.3

-2.72%↓

SHL.DE

48.29

-1.15%↓

ARGX

516.8

-0.96%↓

FRE

43.29

-0.62%↓

SAN

93.2

-0.8%↓

MRK1

114.3

-2.72%↓

SHL.DE

48.29

-1.15%↓

ARGX

516.8

-0.96%↓

FRE

43.29

-0.62%↓

Search

Orion Oyj (Class B)

Închisă

58.65 -2.09

Rezumat

Modificarea prețului

24h

Curent

Minim

58.05

Maxim

59.65

Indicatori cheie

By Trading Economics

Venit

-12M

61M

Vânzări

-80M

355M

P/E

Medie Sector

23.065

54.533

EPS

0.44

Randament dividend

2.87

Marjă de profit

17.287

Angajați

3,943

EBITDA

136M

202M

Dividende

By Dow Jones

Randament dividend

Medie Sector

2.87%

2.41%

Statistici piață

By TradingEconomics

Capitalizare de piață

2.5B

8B

Deschiderea anterioară

60.74

Închiderea anterioară

58.65

Orion Oyj (Class B) Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

21 mai 2025, 23:25 UTC

Acțiuni populare

Stocks to Watch: Navitas Semiconductor, Urban Outfitters, Lumen Technologies, LiveRamp

21 mai 2025, 21:57 UTC

Achiziții, Fuziuni, Preluări

AT&T to Buy Lumen's Mass Markets Fiber Business for $5.75 Billion -- Update

21 mai 2025, 21:29 UTC

Achiziții, Fuziuni, Preluări

Millicom to Acquire Telefónica's Operations in Uruguay

21 mai 2025, 21:01 UTC

Principalele dinamici ale pieței

Nvidia Selects Navitas Semiconductor to Work on Next-Generation 800V HVDC Architecture

21 mai 2025, 23:49 UTC

Market Talk

Gold Edges Higher on Possible Investor Shift Away From Government Bonds -- Market Talk

21 mai 2025, 23:37 UTC

Market Talk

Nikkei May Fall, Tracking Wall Street's Losses -- Market Talk

21 mai 2025, 23:33 UTC

Achiziții, Fuziuni, Preluări

Vigil Neuroscience: Iluzanebart Return to Licensor Amgen to Occur Prior to Closing of Sanofi Deal

21 mai 2025, 23:32 UTC

Achiziții, Fuziuni, Preluări

Vigil Neuroscience Sees Sanofi Deal Strengthening Development Path for Oral Small Molecule TREM2 Agonist Program

21 mai 2025, 23:32 UTC

Achiziții, Fuziuni, Preluări

Vigil Neuroscience: Shareholders to Get Up to $10 a Share in Sanofi Deal >SAN.FR VIGL

21 mai 2025, 23:32 UTC

Market Talk
Achiziții, Fuziuni, Preluări

James Hardie's Weak Update Spurs Questions Before AZEK Vote -- Market Talk

21 mai 2025, 23:31 UTC

Achiziții, Fuziuni, Preluări

Samsung Biologics: Remaining Entity to Focus on Contract Development & Manufacturing Organization Business

21 mai 2025, 23:30 UTC

Achiziții, Fuziuni, Preluări

Samsung Biologics: Spun-Off Entity Tentatively Named Samsung Episholdings

21 mai 2025, 23:30 UTC

Achiziții, Fuziuni, Preluări

Samsung Biologics: Separated Business Entity to Focus on R&D Affiliate Samsungbioepis, New Investment

21 mai 2025, 23:29 UTC

Achiziții, Fuziuni, Preluări

Samsung Biologics to Spin off R&D Segment Into Separate Holdings Company

21 mai 2025, 23:28 UTC

Câștiguri

Singtel to Finance Buybacks Via Excess Capital Generated From Asset Recycling >Z74.SG

21 mai 2025, 23:27 UTC

Câștiguri

Singtel Sets Up S$2.0B Share-Buyback Program >Z74.SG

21 mai 2025, 23:26 UTC

Câștiguri

Singtel: Net Rose Due to Exceptional Gain From Partial Divestment of Comcentre Headquarters >Z74.SG

21 mai 2025, 23:26 UTC

Câștiguri

Singtel FY25 Rev S$14.15B Vs. S$14.13B >Z74.SG

21 mai 2025, 23:26 UTC

Câștiguri

Singtel FY25 Net S$4.02B Vs. Net S$795.0M >Z74.SG

21 mai 2025, 23:23 UTC

Achiziții, Fuziuni, Preluări

Sanofi: VGL101, Vigil's Second Molecule Program, Isn't Being Acquired

21 mai 2025, 23:22 UTC

Top știri

Walmart to Cut 1,500 Corporate Jobs in Restructuring -- WSJ

21 mai 2025, 23:22 UTC

Achiziții, Fuziuni, Preluări

Sanofi Sees No Effect From Vigil Deal on 2025 Outlook >SAN.FR

21 mai 2025, 23:20 UTC

Achiziții, Fuziuni, Preluări

Sanofi: Vigil Deal Enhances Early-Stage Pipeline, Includes VG-3927, Which Will Be Evaluated in Alzheimer's Disease Study

21 mai 2025, 23:18 UTC

Achiziții, Fuziuni, Preluări

Sanofi to Buy Vigil Neuroscience for $8 a Share at Closing >SAN.FR VIGL

21 mai 2025, 23:04 UTC

Top știri

EV Owners Face Annual Fee Under Proposed Tax Bill -- Barrons.com

21 mai 2025, 21:46 UTC

Top știri

NBCUniversal Bids for MLB Rights That Were Dropped by ESPN -- WSJ

21 mai 2025, 21:42 UTC

Top știri
Achiziții, Fuziuni, Preluări

AT&T to Buy Lumen's Mass Markets Fiber Business for $5.75B -- Update

21 mai 2025, 21:14 UTC

Achiziții, Fuziuni, Preluări

Millicom to Acquire Telefónica's Ops in Uruguay

21 mai 2025, 21:07 UTC

Top știri

NBCUniversal Bids for Major League Baseball Rights ESPN Dropped, Sources Say -- WSJ

21 mai 2025, 21:06 UTC

Achiziții, Fuziuni, Preluări

Uber Stock Is Dropping. Blame Elon Musk and Tesla. -- Barrons.com

Comparație

Modificare preț

Orion Oyj (Class B) Așteptări

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Orion Oyj (Class B)

Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. The company provides prescription drugs and self-care products, which includes Nubeqa for the treatment of prostate cancer; Precedex, Dexdor, and Precedex for human use; Burana for inflammatory pain; Divina series for menopausal symptoms; Trexan for rheumatoid arthritis and cancer; Stalevo, Entacapone, and Comtess/Comtan for Parkinson's disease; Biosimilars for rheumatoid arthritis and inflammatory bowel diseases; and Simdax for acute decompensated heart failure, as well as Fareston for breast cancer. It also offers Salmeterol/fluticasone Easyhaler, Budesonide/formoterol Easyhaler, Formoterol Easyhaler, Budesonide Easyhaler, Beclomet Easyhaler, and Buventol Easyhaler drugs for the treatment of asthma and chronic obstructive pulmonary disease. In addition, the company provides veterinary drugs comprising Bonqat, Clevor, Domosedan, Domitor, Antisedan, Dexdomitor, Domosedan Gel, Sileo, and Tessie; APIs for generic compounds and proprietary products, as well as contract manufacturing services; and markets and sells veterinary drugs manufactured by other international companies. It has partnership with Propeller Health to connect the Easyhaler(R) product portfolio; collaboration and option to license agreement with Abilita Therapeutics to develop innovative antibody therapeutics; and a research collaboration and license agreement with Amneal Pharmaceuticals, Inc. to commercialize Amneal's generic products. Orion Oyj was founded in 1917 and is headquartered in Espoo, Finland.